Several Indian companies have reported their third-quarter earnings, showcasing varied financial performances. JB Chemicals recorded a net profit increase of 21.6% to ₹162.5 crore, with revenue rising 14.1% to ₹963.5 crore. Tilaknagar Industries, however, saw a 23.1% rise in net profit to ₹53.9 crore despite a revenue decline of 9.6% to ₹340.4 crore. Zydus Lifesciences reported a 30% increase in net profit to ₹1,023 crore, driven by strong demand for its generic drugs, with revenue up 17% to ₹5,269 crore. Abbott India also posted a net profit increase of 16% to ₹360.8 crore, with revenue rising 12.3% to ₹1,614.3 crore. In contrast, Sula Vineyards experienced a 34.9% drop in net profit to ₹28 crore and a slight revenue decline of 1.4% to ₹200 crore. Emcure Pharma reported a 30.3% increase in net profit to ₹156 crore, while Sapphire reported an 18% rise in net profit to ₹12 crore. Overall, the earnings reflect a mix of growth and challenges across different sectors.